Speakers: Wayne R. Hogrefe, Ph.D. and Patrick Hurban, Ph.D.
Vaccine design and therapeutic modalities are rapidly evolving. This webinar presentation provides a brief overview of influenza vaccine development from eggs to recombinant proteins, followed by an introduction to a sequence-based typing method of influenza strains and the advantages of a next generation sequencing (NGS) approach. Then, we discuss how our NGS influenza typing assay can be leveraged to facilitate vaccine and therapeutic development, and how it can provide further insight into the molecular evolution of the influenza virus.
Key Learning Objectives:
- Gain understanding of the evolution of Influenza vaccine development
- Discover how our NGS assay fits into data requirements for vaccine efficacy
- Learn how the assay can be used for future vaccine design, therapeutics, and influenza natural history
Download our webcast presentation or watch on demand.
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
